Association of vitamin D and incident statin induced myalgia - a retrospective cohort study

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Palamaner Subash Shantha, Ghanshyam ^a   Ramos, Julio ^a   Thomas Hemak, Linda ^a   Pancholy, Samir Bipin ^a  

^a Wright Center for Graduate Medical Education   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CALCIFEDIOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; VITAMIN D;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYALGIA; PREDICTIVE VALUE; PRIMARY MEDICAL CARE; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATIN INDUCED MYALGIA; UNITED STATES; VITAMIN BLOOD LEVEL; VITAMIN D BLOOD LEVEL; VITAMIN D DEFICIENCY; AGED; BLOOD; CHEMICALLY INDUCED; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; MIDDLE AGED; MYALGIA; PENNSYLVANIA; RETROSPECTIVE STUDIES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84896770249     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088877     Document Type: Article

References (31)

1. Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, et al. (2013) Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 1:CD004816. doi: 10.1002/14651858.CD004816.pub5.
2. Reiner Z (2013) Statins in the primary prevention of cardiovascular disease. Nat Rev Cardiol. doi: 10.1038/nrcardio.2013.80.
3. Sheng X, Murphy MJ, MacDonald TM, Wei L (2012) Effect of statins on total cholesterol concentrations and cardiovascular outcomes in patients with diabetes mellitus: a population-based cohort study. Eur J Clin Pharmacol. 68(8):1201-8. doi: 10.1007/s00228-012-1234-5.
4. Hung CY, Lin CH, Loh el-W, Ting CT, Wu TJ, et al. (2013) CHADS(2) score, statin therapy, and risks of atrial fibrillation.Am J Med. 126(2):133-40. doi:10.1016/j.amjmed.2012.06.027.
5. Aboa-Eboulé C, Binquet C, Jacquin A, Hervieu M, Bonithon-Kopp C, et al. (2013) Effect of previous statin therapy on severity and outcome in ischemic stroke patients: a population-based study. J Neurol. 260(1):30-7.
6. Douglas I, Evans S, Smeeth L (2011) Effect of statin treatment on short term mortality after pneumonia episode: cohort study. BMJ. 342:d1642.
7. Wu XD, Zeng K, Xue FQ, Chesn JH, Chen YQ, et al. (2013) Statins are associated with reduced risk of gastric cancer: A meta-analysis. Eur J Clin Pharmacol.
8. Heeschen C, Hamm CW, Laufs U, Snapinn S, Böhm M, et al. (2002) Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation. 105:1446-52. (Pubitemid 34263276)
9. Wei L, Wang J, Thompson P, Wong S, Struthers AD, et al. (2002) Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart 88:229-33. (Pubitemid 34913500)
10. Avorn J, Monette J, Lacour A, Bohn RL, Monane M, et al. (1998) Persistence of use of lipid-lowering medications: a cross-national study. JAMA 279:1458-62. (Pubitemid 28228203)
11. Ellis JJ, Erickson SR, Stevenson JG, Bernstein SJ, Stiles RA, et al. (2004) Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med 19:638-45.
12. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, et al. (2002) Long-term persistence in use of statin therapy in elderly patients. JAMA. 288:455-61. (Pubitemid 34787476)
13. Jackevicius CA, Mamdani M, Tu JV (2002) Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 288:462-7. (Pubitemid 34787477)
14. Garavalia L, Garavalia B, Spertus JA, Decker C (2009) Exploring patients' reasons for discontinuance of heart medications. J Cardiovasc Nurs. 24:371-9.
15. Fung V, Sinclair F, Wang H, Dailey D, Hsu J, et al (2010) Patients' perspectives on nonadherence to statin therapy: a focus-group study. Perm J. 14:4-10.
16. Zhang H, Plutzky J, Skentzos S, Morrison F, Mar P, et al. (2013) Discontinuation of statins in routine care settings: a cohort study. Ann Intern Med. 158(7):526-34.
17. Lee P (2009) Vitamin D insufficiency- a novel mechanism of statin induced myalgia. Clin Endocrinol (Oxf). 71(1): 154-5.
18. Ahmed W, Khan N, Glueck CJ, Pandey S, Wang P, et al. (2009) Low serum 25 (OH) vitamin D levels are associated with reversible myositis-myalgia in statin-treated patients. Transl Res. 153(1):11-6.
19. Kurnik D, Hochman I, Vesterman-Landes J, Kenig T, Katzir I, et al. (2012) Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins. Clin Endocrinol (Oxf). 77(1):36-41.
20. Riphagen IJ, van der Veer E, Muskiet FA, DeJongste MJ (2012) Myopathy during statin therapy in the daily practice of an outpatient cardiology clinic: prevalence, predictors and relation with vitamin D. Curr Med Res Opin. 28(7):1247-52.
21. Jeffrey SF, Eleftheria MF (2005) Obesity. In: DL KasperE. BraunwaldAS FauciSL HauserDL Longo. Harrison's Principles of Internal Medicine. New York: McGraw Hill Inc. pp. 422-423.
22. Greenberg RS, Daniels SR, Dana Flanders W, Sanders FH, Robert RB (2005) Diagnostic testing. In: RS Greenberg. Medical Epidemiology. New York: McGraw-Hill Inc. pp. 112-117.
23. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 44(3):837-845.
24. StataCorp (2009) Stata Statistical Software: Release 11. College Station, TX: StataCorp LP.
25. DiNicolantonio JJ (2012) CoQ10 and L-carnitine for statin myalgia? Expert Rev Cardiovasc Ther. 10(10):1329-33. doi: 10.1586/erc.12.92.
26. PäiväH, Thelen KM, Van Coster R, Smet J, De Paepe B, et al (2005) High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. Clin Pharmacol Ther. 78(1):60.
27. Ruaño G, Windemuth A, Wu AH, Kane JP, Malloy MJ, et al (2011) Mechanisms of statin-induced myalgia assessed by physiogenomic associations. Atherosclerosis. 218(2):451-6. doi: 10.1016/j.atherosclerosis.2011.07.007.
28. Gupta RP, He YA, Patrick KS, Halpert JR, Bell NH (2005) CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis. Journal of Clinical Endocrinology and Metabolism 90:1210-1219. (Pubitemid 40279256)
29. Gupta A, Thompson PD (2011) The relationship of vitamin D deficiency to statin myopathy. Atherosclerosis. 2011;215(1):23-9. doi: 10.1016/j. atherosclerosis.2010.11.039.
30. Abd TT, Jacobson TA (2011) Statin-induced myopathy: a review and update. Expert Opin Drug Saf.10(3):373-87. doi: 10.1517/14740338.2011.540568.
31. Hewitt NA, O'Connor AA, O'Shaughnessy DV, Elder GJ (2013) Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients. Clin J Am Soc Nephrol. 8(7):1143-9. doi: 10.2215/CJN.02840312.